Handheld Thermo-Photonic Device for Rapid, Low-Cost, and On-Site Detection and Quantification of Anti-SARS-CoV-2 Antibody

Overview

Journal IEEE Sens J

Date 2022 May 18

PMID 35581990

Authors

Damber Thapa

Nakisa Samadi

Nima Tabatabaei

Affiliations

Soon will be listed here.

Abstract

With the emergence of vaccines and antibody therapeutics, rapid and scalable platforms are needed to quantify the antibody response of individuals. Lateral flow immunoassay (LFA) based test strips provide a rapid, low-cost, and point-of-care approach to antibody testing against the SARS-CoV-2 virus. These convenient and scalable tests, however, are qualitative in nature and cannot quantify the immune response of the infected and/or vaccinated individuals. This study reports on the development of a rapid, low cost and portable thermo-photonic device that enables sensitive detection and quantification of antibody levels using commercially available COVID-19 Antibody LFAs. Unlike conventional LFA readers, the developed technology is based on sensing the infrared thermal radiation of tag gold nanoparticles following laser excitation (aka photothermal response). Our proof-of-concept results with humanized monoclonal anti-SARS-CoV-2 Spike receptor-binding domain (RBD) IgG demonstrate that the thermo-photonic technology can detect and quantify antibody concentrations within the clinically relevant range and with a limit of detection of [Formula: see text]/ml. The reader in conjunction with antibody LFAs offers a low-cost, portable, and scalable solution for assessment of the degree of immunity in populations, quality control of convalescent plasma donations for antibody therapeutics, and monitoring the immune response of infected individuals and vaccine recipients.

Citing Articles

Rapid Detection of SARS-CoV-2 Based on the LAMP Assay Associated with the CRISPRCas12a System.

de Sousa K, Nonaka C, Khouri R, Gurgel Rocha C, Regis-Silva C, Souza B Diagnostics (Basel). 2023; 13(13).

PMID: 37443626 PMC: 10341061. DOI: 10.3390/diagnostics13132233.

Polydopamine Nanoparticles-Based Three-Line Lateral Flow Immunoassay for COVID-19 Detection.

Liu Z, Cao C, Tong H, You M Biosensors (Basel). 2023; 13(3).

PMID: 36979563 PMC: 10046468. DOI: 10.3390/bios13030352.

Handheld, Low-Cost, Aptamer-Based Sensing Device for Rapid SARS-CoV-2 RNA Detection Using Novelly Synthesized Gold Nanoparticles.

Kiruba Daniel S, Pai P, Sabbella H, Singh K, Rangaiah A, Basawarajappa S IEEE Sens J. 2022; 22(19):18437-18445.

PMID: 36416744 PMC: 9647715. DOI: 10.1109/JSEN.2022.3196598.

Rapid and Low-Cost Detection and Quantification of SARS-CoV-2 Antibody Titers of ICU Patients with Respiratory Deterioration Using a Handheld Thermo-Photonic Device.

Thapa D, Samadi N, Baker A, Dos Santos C, Trahtemberg U, Tabatabaei N Biomedicines. 2022; 10(6).

PMID: 35740446 PMC: 9220023. DOI: 10.3390/biomedicines10061424.

References

Ojaghi A, Parkhimchyk A, Tabatabaei N . First step toward translation of thermophotonic lock-in imaging to dentistry as an early caries detection technology. J Biomed Opt. 2016; 21(9):96003. DOI: 10.1117/1.JBO.21.9.096003. View

Huang C, Wen T, Shi F, Zeng X, Jiao Y . Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay. ACS Omega. 2020; 5(21):12550-12556. PMC: 7241732. DOI: 10.1021/acsomega.0c01554. View

Tanne J . Covid-19: FDA approves use of convalescent plasma to treat critically ill patients. BMJ. 2020; 368:m1256. DOI: 10.1136/bmj.m1256. View

Bosnjak B, Stein S, Willenzon S, Cordes A, Puppe W, Bernhardt G . Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods. Cell Mol Immunol. 2020; 18(4):936-944. PMC: 7604543. DOI: 10.1038/s41423-020-00573-9. View

Muruato A, Fontes-Garfias C, Ren P, Garcia-Blanco M, Menachery V, Xie X . A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2020; 11(1):4059. PMC: 7426916. DOI: 10.1038/s41467-020-17892-0. View

Thapa D, Samadi N, Patel N, Tabatabaei N . Thermographic detection and quantification of THC in oral fluid at unprecedented low concentrations. Biomed Opt Express. 2020; 11(4):2178-2190. PMC: 7173880. DOI: 10.1364/BOE.388990. View

Weidner L, Gansdorfer S, Unterweger S, Weseslindtner L, Drexler C, Farcet M . Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays. J Clin Virol. 2020; 129:104540. PMC: 7336952. DOI: 10.1016/j.jcv.2020.104540. View

Chen Z, Zhang Z, Zhai X, Li Y, Lin L, Zhao H . Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay. Anal Chem. 2020; 92(10):7226-7231. DOI: 10.1021/acs.analchem.0c00784. View

Ibarrondo F, Fulcher J, Goodman-Meza D, Elliott J, Hofmann C, Hausner M . Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19. N Engl J Med. 2020; 383(11):1085-1087. PMC: 7397184. DOI: 10.1056/NEJMc2025179. View

10.

Hsueh P, Huang L, Chen P, Kao C, Yang P . Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clin Microbiol Infect. 2004; 10(12):1062-6. PMC: 7129952. DOI: 10.1111/j.1469-0691.2004.01009.x. View

11.

Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020; 26(8):1200-1204. DOI: 10.1038/s41591-020-0965-6. View

12.

Theel E, Slev P, Wheeler S, Couturier M, Wong S, Kadkhoda K . The Role of Antibody Testing for SARS-CoV-2: Is There One?. J Clin Microbiol. 2020; 58(8). PMC: 7383527. DOI: 10.1128/JCM.00797-20. View

13.

Xiong S, Wang Y, Zhang M, Liu X, Zhang C, Liu S . Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunol Lett. 2004; 95(2):139-43. PMC: 7112924. DOI: 10.1016/j.imlet.2004.06.014. View

14.

Li J, Ulitzky L, Silberstein E, Taylor D, Viscidi R . Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates. Viral Immunol. 2013; 26(2):126-32. PMC: 3624630. DOI: 10.1089/vim.2012.0076. View

15.

Shokouhi E, Razani M, Gupta A, Tabatabaei N . Comparative study on the detection of early dental caries using thermo-photonic lock-in imaging and optical coherence tomography. Biomed Opt Express. 2019; 9(9):3983-3997. PMC: 6157756. DOI: 10.1364/BOE.9.003983. View

16.

Kasetsirikul S, Umer M, Soda N, Sreejith K, Shiddiky M, Nguyen N . Detection of the SARS-CoV-2 humanized antibody with paper-based ELISA. Analyst. 2020; 145(23):7680-7686. DOI: 10.1039/d0an01609h. View

17.

Peng T, Liu X, Adams L, Agarwal G, Akey B, Cirillo J . Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2. Appl Phys Lett. 2020; 117(12):120601. PMC: 7518548. DOI: 10.1063/5.0021842. View

18.

Azkur A, Akdis M, Azkur D, Sokolowska M, Veen W, Bruggen M . Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020; 75(7):1564-1581. PMC: 7272948. DOI: 10.1111/all.14364. View

19.

Dobano C, Vidal M, Santano R, Jimenez A, Chi J, Barrios D . Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 Antigens. J Clin Microbiol. 2020; 59(2). PMC: 8111153. DOI: 10.1128/JCM.01731-20. View

20.

Petherick A . Developing antibody tests for SARS-CoV-2. Lancet. 2020; 395(10230):1101-1102. PMC: 7270070. DOI: 10.1016/S0140-6736(20)30788-1. View